Cogent Biosciences Stock Soars: A Year of Gains and a $4.5M Sell
Cogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
Index Level signals can help align your purchase or sale timing with market momentum, giving you a clearer framework for decisions and risk control.
25,526 articlesCogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
Bank of America Global Research argues the housing crisis is driven by years of underbuilding and local policy barrie...
A sizable stake in Pampa Energia signals renewed interest in Argentina's energy complex. This article breaks down wha...
SpaceX stunned markets by setting a fixed IPO price of $135. Is this a bold power move or a warning sign for investor...
Two SUI spot ETFs kicked off trading in the U.S. on Feb. 18, 2026, yet debut volume was muted. The scene highlights t...
A fresh health-economics study links the use of GLP-1 obesity drugs to sizable lifetime medical cost reductions for 4...
When family life takes center stage, careers and finances shift. Explore practical ways motherhood and life changes i...
Starting with $1,000, you can build a dependable dividend-focused plan. Learn what makes the smartest dividend stock ...
coca-cola just all-time high marks a moment of momentum for KO, while PepsiCo sits below its peak with a different ri...
Netflix has fallen sharply, but a trough like this can hide opportunity. This guide breaks down what drove the declin...
Rivian has faced volatility, with a notable pullback this year. This guide breaks down what’s driving the moves, what...
A major fund is doubling down on Lionsgate Studios as shares skyrocket. Learn what know about this bet, the strategy ...